Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2)
David H. Birnie, Jeff S. Healey, George A. Wells, Felix Ayala-Paredes, Benoit Coutu, Glen L. Sumner, Giuliano Becker, Atul Verma, François Philippon, Eli Kalfon, John Eikelboom, Roopinder K. Sandhu, Pablo B. Nery, Nicholas Lellouche, Stuart J. Connolly, John Sapp, Vidal Essebag
Dive into the research topics of 'Continued vs. interrupted direct oral anticoagulants at the time of device surgery, in patients with moderate to high risk of arterial thrombo-embolic events (BRUISE CONTROL-2)'. Together they form a unique fingerprint.